MegaPro Biomedical completed capital increase and introduced new strategic partners
02-27-2025
MegaPro Biomedical completed capital increase and introduced new strategic partners MegaPro Biomedical is a start-up company focusing on the development of nano drug dosage forms and has successfully...
MPB-1734 new dosage form anticancer drug has passed the US…
02-27-2025
MPB-1734 new dosage form anticancer drug has passed the US FDA clinical I/IIa IND application The MPB-1734 new dosage form anticancer drug developed by MegaPro Biomedical has passed the revie...
Error: No articles to display